Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal rod cell | 7 studies | 31% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 4 studies | 26% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 52% | 2.19 | 11 / 21 | 0% | 0.01 | 2 / 504 |
| esophagus | 39% | 2.07 | 561 / 1445 | 2% | 0.06 | 3 / 183 |
| stomach | 31% | 1.16 | 113 / 359 | 1% | 0.04 | 4 / 286 |
| intestine | 31% | 1.48 | 300 / 966 | 0% | 0.00 | 2 / 527 |
| prostate | 31% | 6.49 | 75 / 245 | 0% | 0.00 | 1 / 502 |
| breast | 28% | 2.36 | 127 / 459 | 0% | 0.00 | 2 / 1118 |
| brain | 11% | 0.34 | 301 / 2642 | 16% | 3.40 | 115 / 705 |
| adipose | 26% | 1.17 | 316 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 25% | 2.48 | 42 / 170 | 0% | 0.01 | 2 / 459 |
| pancreas | 24% | 0.63 | 79 / 328 | 0% | 0 | 0 / 178 |
| ovary | 24% | 0.58 | 43 / 180 | 0% | 0 | 0 / 430 |
| thymus | 23% | 1.85 | 150 / 653 | 0% | 0 | 0 / 605 |
| adrenal gland | 19% | 0.70 | 50 / 258 | 3% | 0.13 | 6 / 230 |
| spleen | 21% | 0.63 | 51 / 241 | 0% | 0 | 0 / 0 |
| lung | 20% | 0.77 | 114 / 578 | 0% | 0.01 | 5 / 1155 |
| heart | 18% | 0.69 | 159 / 861 | 0% | 0 | 0 / 0 |
| liver | 18% | 1.83 | 41 / 226 | 0% | 0 | 0 / 406 |
| blood vessel | 18% | 0.92 | 234 / 1335 | 0% | 0 | 0 / 0 |
| kidney | 17% | 0.81 | 15 / 89 | 0% | 0.01 | 4 / 901 |
| skin | 15% | 0.92 | 279 / 1809 | 0% | 0 | 0 / 472 |
| peripheral blood | 12% | 0.34 | 112 / 929 | 0% | 0 | 0 / 0 |
| muscle | 11% | 0.95 | 91 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 6% | 1.54 | 5 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050829 | Biological process | defense response to Gram-negative bacterium |
| GO_0061760 | Biological process | antifungal innate immune response |
| GO_0050830 | Biological process | defense response to Gram-positive bacterium |
| GO_0005576 | Cellular component | extracellular region |
| GO_0001530 | Molecular function | lipopolysaccharide binding |
| Gene name | DEFB119 |
| Protein name | Beta-defensin 119 (Beta-defensin 120) (Beta-defensin 19) (DEFB-19) (Beta-defensin 20) (DEFB-20) (Defensin, beta 119) (Defensin, beta 120) (ESC42-RELA) |
| Synonyms | UNQ2449/PRO5729 DEFB20 DEFB120 DEFB19 |
| Description | FUNCTION: Has antibacterial activity. . |
| Accessions | ENST00000339144.3 [Q8N690-3] Q8N690 ENST00000376315.2 [Q8N690-2] ENST00000376321.4 [Q8N690-1] |